Shares of Micromet MITI are higher on the session by 0.16%, currently trading at $6.44. The stock has been moving largely higher over the past two months and is currently trading above the 50-day moving average.
Options traders are focusing on calls today. A short while ago the February 2012 $7.50 call traded 980 times on open interest of 731 contracts.
Calls are outpacing puts today by 1,000 to 1.
Micromet, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of antibody-based therapies for the treatment of cancer.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in